INNODIA
Innodia is a privately held biopharmaceutical company with the mission of developing and bringing new drugs.
INNODIA
Industry:
Biotechnology Health Care Medical
Founded:
2003-01-01
Address:
Laval, Quebec, Canada
Country:
Canada
Website Url:
http://www.innodia-inc.com
Total Employee:
1+
Status:
Closed
Contact:
(450)781-8818
Total Funding:
3 M USD
Technology used in webpage:
Domain Not Resolving
Investors List
CDP Capital Technology Ventures
CDP Capital Technology Ventures investment in Venture Round - Innodia
Official Site Inspections
http://www.innodia-inc.com
- Host name: ac1a2ad24832d38a2.awsglobalaccelerator.com
- IP address: 75.2.18.233
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Innodia"
INNODIA - We accelerate the development of therapies to …
INNODIA is the largest European Network dedicated to preventing and curing type 1 diabetes and represents the point of contact between those who want to develop new therapies and those …See details»
Our story | INNODIA
INNODIA is an international non-profit organization that stemmed from an European-based public private partnership co-funded by the European Commission’s Innovative Medicines Initiative (IMI-JU Joint Undertaking), The …See details»
About us - INNODIA
INNODIA is an international non-profit organization that stemmed from an European-based public private partnership co-funded by the European Commission’s Innovative Medicines Initiative (IMI), The Hemsley Charitable …See details»
About INNODIA and its goal
INNODIA is a global partnership between 31 academic institutions, 6 industrial partners, a small sized enterprise and 2 patient organisations, bringing their knowledge and experience together with one common goal: 'To fight Type 1 …See details»
INNODIA - LinkedIn
INNODIA is an international non-for-profit organization that accelerates the development of therapies to prevent and cure type 1 diabetes. INNODIA convenes entities often with different …See details»
Innodia - Crunchbase Company Profile & Funding
Innodia is a privately held biopharmaceutical company with the mission of developing and bringing new drugs.See details»
INNODIA — Oslo Diabetes Research Center
INNODIA is a EU-IMI2-consortium with 40 partners: 31 academic institutions and clinics, 6 industrial partners and 2 patient organizations and one SME. In fall 2020, 4 INNODIA clinical …See details»
Type 1 diabetes research - INNODIA
Overview Innodia Despite significant progress in preclinical type 1 diabetes research the important findings from in vitro models and animal studies could not yet be translated into novel and effective clinical interventions with earlier …See details»
Innodia Inc. - VentureRadar
Innodia Inc. VentureRadar profile. Find out more about Innodia Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Who we are | INNODIA
INNODIA is made of a governing board driving all major decisions upon approval from the general assembly, a managing team steering the organization, and an expert community of people and families living with type 1 diabetes that flanks …See details»
Innodia - Products, Competitors, Financials, Employees, …
Innodia Inc is a biotechnology company engaged in taking to the market drugs for the treatment of type 2 diabetes and related diseases and in generating value for its shareholders. Use the CB …See details»
Innodia Company Profile 2024: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for Innodia. Use the PitchBook Platform to explore the full profile.See details»
Innodia Company Profile | Management and Employees List
Innodia Profile and History INNODIA is a global partnership between 26 academic institutions, 4 industrial partners, a small sized enterprise and 2 patient organisations, bringing their …See details»
For people with Type 1 Diabetes - INNODIA
INNODIA has brought together diabetes experts from across Europe and conducted a study in type1 diabetes to discover new factors to predict the risk of developing the disease, and new …See details»
INNODIA PUBLICATION POLICY
DEFINITIONS INNODIA iVZW – the international non-for-profit organization with registered office in Herestraat 49, Onderwijs en Navorsing 1bis, box 902, 3000 Leuven (Belgium), registered …See details»
Innodia: A Collaboration to End T1D - Breakthrough T1D
May 12, 2020 Innodia is a collaboration between the leading charitable funders of T1D research, including Breakthrough T1D, Helmsley Charitable Trust, and more.See details»
Innodia Inc. - Laval, Canada - bionity.com
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.See details»
Our members | INNODIA
We are made up of members that share INNODIA’s vision and values and contribute to INNODIA’s mission as accredited clinical trial sites, research and innovation labs, and GLP …See details»
INNODIA Web Apps
What's Next? Now you're ready to try one of our dashboards. On the right side of this page, you will see one of our dashboards: INNODIA Counts.See details»
Our services | INNODIA
We deliver customized services to accelerate and de-risk the development of curative therapies for people living with type 1 diabetes and gain the most from every study. We are the interface …See details»